Stock Events

Stock Events

Disruptive Pharma AB 

SEK1.2200
0
-SEK0.01-1.13% Thursday 14:01

Statistics

Day High
1.288
Day Low
1.062
52W High
1.6
52W Low
1.062
Volume
4,494
Avg. Volume
56,818
Mkt Cap
24.6M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12NovExpected
Q4 2022
Q2 2026
Next
-5.72
-5.39
-5.06
-4.72
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-108.85MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Vertex Pharmaceuticals
VRTX
Mkt Cap137.3B
Vertex Pharmaceuticals, involved in treating cystic fibrosis and other serious diseases, overlaps with Guard's focus on critical care.
AMGEN
AMGN
Mkt Cap233.78B
Amgen, a biotech firm working on innovative therapies including for kidney diseases, aligns with Guard's renal protection products.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals, known for its innovative biopharmaceuticals, competes in the space of novel therapies for complex diseases.
Biomarin Pharmaceutical
BMRN
Mkt Cap12.52B
BioMarin Pharmaceutical, specializes in enzyme replacement therapies, competing in the broader market of rare disease treatments.
Novo Nordisk
NVO
Mkt Cap201.64B
Novo Nordisk, with a strong presence in diabetes care, indirectly competes in the metabolic and endocrine areas relevant to kidney health.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences, a leader in antiviral drugs and other serious medical conditions, shares a focus on innovative, life-saving treatments.
Biogen
BIIB
Mkt Cap32.28B
Biogen, focuses on neurological and neurodegenerative diseases, competes in the high-stakes biotech space for groundbreaking therapies.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca, a global biopharmaceutical company, has a diverse portfolio that includes treatments for kidney-related conditions.
Pfizer
PFE
Mkt Cap159.36B
Pfizer, one of the largest pharmaceutical companies, competes across various therapeutic areas including those relevant to Guard's interests.

About

Disruptive Pharma Holding Ab (Publ) operates as a pharmaceutical technology company that develops and commercializes patented platform technology for the formulation and development of pharmaceutical products. The company was incorporated in 2021 and is based in Uppsala, Sweden.
Show more...
CEO
Mr. Peter Åsberg Ph.D.
Employees
12
Country
Sweden
ISIN
SE0021181559
WKN
000A3E2EN

Listings

ST
SE
DPHA.ST
MU
DE
5LH0.MU
ST
SE
GUARD-BTA.ST
F
DE
5LH0.F

0 Comments

Share your thoughts

FAQ

What is Disruptive Pharma AB stock price today?▼
The current price of DPHA.ST is SEK1.22 SEK — it has decreased by -1.13% in the past 24 hours. Watch Disruptive Pharma AB stock price performance more closely on the chart.
What is Disruptive Pharma AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange Disruptive Pharma AB stocks are traded under the ticker DPHA.ST.
What is Disruptive Pharma AB market cap?▼
Today Disruptive Pharma AB has the market capitalization of 24.6M
When is the next Disruptive Pharma AB earnings date?▼
Disruptive Pharma AB is going to release the next earnings report on November 12, 2026.
What is Disruptive Pharma AB revenue for the last year?▼
Disruptive Pharma AB revenue for the last year amounts to 0 SEK.
What is Disruptive Pharma AB net income for the last year?▼
DPHA.ST net income for the last year is -108.85M SEK.
How many employees does Disruptive Pharma AB have?▼
As of September 04, 2026, the company has 12 employees.
In which sector is Disruptive Pharma AB located?▼
Disruptive Pharma AB operates in the Other sector.
When did Disruptive Pharma AB complete a stock split?▼
Disruptive Pharma AB has not had any recent stock splits.
Where is Disruptive Pharma AB headquartered?▼
Disruptive Pharma AB is headquartered in Uppsala, Sweden.